Mapping the Complement Factor H-Related Protein 1 (CFHR1):C3b/C3d Interactions
Jonathan P Hannan1, Jennifer Laskowski1, Joshua M Thurman1
1Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
Plos One
|November 5, 2016
Summary
Complement factor H-related protein 1 (CFHR1) regulates complement by binding to C3b and C3d. Dimerized CFHR1 competes with complement factor H (CFH) and CFH-like protein 1 (CFHL-1) for these binding sites.
Area of Science:
- Immunology
- Molecular Biology
Background:
- Complement factor H-related protein 1 (CFHR1) is a known regulator of the complement system.
- CFHR1 inhibits complement by blocking C5 convertase activity and interfering with C5b surface binding.
- CFHR1 antagonizes complement factor H (CFH) regulation on cell surfaces by competing for C3b binding.
Purpose of the Study:
- To identify the specific binding interface of CFHR1 with complement components C3b and C3d.
- To determine the role of CFHR1 dimerization in its interaction with C3b/C3d and CFH.
- To investigate the competitive binding of CFHR1 with CFH and CFH-like protein 1 (CFHL-1).
Main Methods:
- Site-directed mutagenesis was employed to pinpoint the CFHR1 binding interface.
- ELISA-based and functional assays were utilized to analyze binding interactions.
- Competitive binding assays were performed using CFH and CFHL-1.
Main Results:
- A single, shared interface was identified for CFHR1 binding to C3b and C3d.
- This interface is identical to the C3b binding site of CFH's C-terminal domains (SCR19-20).
- CFHR1 dimerization is essential for effective binding to C3b/C3d and competition with CFH.
- CFHR1 competes with CFHL-1 for C3b binding, blocking both N- and C-terminal CFH interactions with C3b.
Conclusions:
- CFHR1 binds C3b and C3d via a specific interface involving its C-terminal domains.
- CFHR1 dimerization is crucial for its regulatory function and competition with CFH.
- CFHR1 acts as a potent complement regulator by sterically hindering CFH binding to C3b.
Related Concept Videos
Complement System
11.8K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
11.8K
Antimicrobial Proteins
15.2K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
15.2K
Immunoglobulin-like Cell Adhesion Molecules
4.5K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
4.5K
Protein Complexes with Interchangeable Parts
3.0K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
3.0K
Regulation of Hematopoietic Stem Cells
4.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.3K
Hypersensitivity Reactions: Immune-Complex Reactions
82
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
82


